317
Views
160
CrossRef citations to date
0
Altmetric
Research Article

Toxicology and Epidemiology of 1,3-Butadiene

, , , &
Pages 1-108 | Published online: 25 Sep 2008

References

  • Acquavella J. F. The paradox of butadieneEpidemiology. Exp.Pathol. 1989; 37: 114
  • Acquavella J. F., Delzell E., Cole P. Butadiene and lymphopoietic cancers: the authors reply. Epidemiology 1994; 5: 262
  • Adler I.-D., Anderson D. Dominant lethal effects after inhalation exposure to 1,3-butadiene. Mutat. Res 1994; 309: 295
  • Adler I.-D., Cao J., Filser J. G., Gassner Kessler P. W., Kliesch U., Neuhäuser-Klaus A., Nüsse M. Mutagenicity of 1,3-butadiene inhalation in somatic and germinal cells of mice. Mutat. Res 1994; 309: 307
  • Agency for Toxic Substances and Disease Registry (ATSDR), Toxicological Profile for 1,3-Butadiene. U.S. Department of Health and Human Services. 1992, TP-91/07, PB93–110690
  • Albertini R. J., Castle K. L., Borcherding W. R. T-cell cloning to detect the mutant 6-thioguanine-resis-tant lymphocytes present in human peripheral blood. Proc. Natl. Acad. Sci. U.S.A 1982; 79: 6617
  • Amoore J. E., Hautala E. Odor as an aid to chemical safety: odor thresholds compared with threshold limit values and volatilities for 214 industrial chemicals in air and water dilution. J. Appl. Toxicol 1983; 3: 272
  • Andersen M. E. Physiological modelling of organic compounds. Ann. Occup Hyg 1991; 35: 309
  • Andersen M. E., Clewell H. J., III, Gargas M. L., Smith F. A., Reitz R. H. Physiologically based pharma-cokinetics and the risk assessment process for methy-lene chloride. Toxicol. Appl. Pharmacol 1987; 87: 185
  • Anderson D., Edwards A. J., Brinkworth M. H. Male-mediated F1 effects in mice exposed to 1,3-buta-diene. Butadiene and Styrene: Assessment of Health Hazards, M. Sorsa, K. Peltonen, H. Vainio, K. Hemminki. IARC Scientific Publication, Lyon 1993; 127: 171
  • Andjelkovich D., Taulbee J., Symmons M., Williams T. Mortality of rubber workers with reference to work experience. J. Occup. Med 1977; 19: 397
  • Au W. W., Bechtold W. E., Whorton E. B., Jr., Legator M. S. Chromosome aberrations and response to g-ray challenge in lymphocytes of workers exposed to 1,3-butadiene. Mutat. Res 1995; 334: 125
  • Autio K., Renzi L., Catalan J., Albreeht O. E., Sorsa M. Induction of micronuclei in peripheral blood and bone marrow erythrocytes of rats and mice exposed to 1,3-butadiene by inhalation. Mutat. Res 1994; 309: 315
  • Bechtold W. E., Strunk M. R., Chang I.-Y., Ward J. B., Jr., Henderson R. F. Species differences in urinary butadiene metabolites: comparison of metabolite ratios between mice, rats, and humans. Toxicol. Appl. Pharmacol 1994; 127: 44
  • Bechtold W. E., Strunk M. R., Thornton-Manning J. R., Henderson R. F. Analysis of butadiene, butadiene monoxide, and butadiene dioxide in blood by gas chromatography/gas chromatography/mass spectros-copy. Chem. Res. Toxicol 1995; 8: 182
  • Berg S., Frostling H., Jacobsson S. Chemical analysis of fire gases with gas-chromatography-mass spectrom-etry. Proc. Int. Symp. on the Control of Air Pollution in the Work Environment Part 1. Arbetarskyddsfonden., Stockholm 1978; 309
  • Bird M. G. Future directions — toxicology studies of 1,3-butadiene and isoprene. Environ. Health Perspect 1990; 86: 99
  • Birnbaum L. S. A brief survey of butadiene health effects: a role for metabolic differences. Environ. Health Perspect 1993; 101: 161, (Suppl. 6)
  • Bolt H. M., Filser J. G., Störmer F. Inhalation pharmacokinetics based on gas uptake studies. V. Comparative pharmacokinetics of ethylene and 1,3-butadi-ene in rats. Arch. Toxicol 1984; 55: 213
  • Bolt H. M., Sehmiedel G., Filser J. G, Rolzhäuser H. P., Lieser K., Wistuba D., Sehurig V. Biological activation of 1,3-butadiene to vinyl oxirane by rat liver microsomes and expiration of the reactive metabolite by exposed rats. J. Cancer Res. Clin. Oncol 1983; 106: 112
  • Bond J. A., Recio L., Andjelkovich D. Epidemio-logical and mechanistic data suggest that 1,3-butadiene will not be carcinogenic to humans at exposures likely to be encountered in the environment or workplace. Carcinogenesis 1995; 16: 165
  • Bond J. A., Csanády G. A., Leavens T. L., Medinsky M. A. Research strategy for assessing target tissue dosimetry of 1,3-butadiene in laboratory animals and humans. Butadiene and Styrene: Assessment of Health Hazards, M. Sorsa, K. Peltonen, H. Vainio, K. Hemminki. IARC Scientific Publication, Lyon 1993; 127: 45
  • Bond G. G., Bodner K. M., Olsen G. W., Cook R. R. Mortality among workers engaged in the development or manufacture of styrene-based products — an update. Scand. J. Work Environ. Health 1992; 18: 145
  • Bond J. A., Martin O. S., Birnbaum L. S., Dahl A. R., Melnick R. L., Henderson R. F. Metabolism of 1,3-butadiene by lung and liver microsomes of rats and mice repeatedly exposed by inhalation to 1,3-butadiene. Toxicol. Lett 1988; 44: 143
  • Bond J. A., Dahl A. R., Henderson R. F., Birnbaum L. S. Species differences in the distribution of inhaled butadiene in tissues. Am Ind. Hyg. Assoc. J 1987; 48: 867
  • Bond J. A., Dahl A. R., Henderson R. F., Dutcher J. S., Mauderly J. L., Birnbaum L. S. Species differences in the disposition of inhaled butadiene. Toxicol. Appl. Pharmacol 1986; 84: 617
  • Boogaard P. J., Bond J. A. The role of hydrolysis in the detoxication of l,2:3,4-diepoxybutane by human, rat, and mouse liver and lung, in vitro. Toxicol. Appl. Pharmacol 1996; 141: 617
  • Boogaard P. J., Sumner S. C. J., Bond J. A. Glu-tathione conjugation of l,2:3,4-diepoxybutane in human liver and rat and mouse liver and lung in vitro. Toxicol. Appl. Pharmacol 1996; 136: 307
  • Brunnemann K. D., Kagan M. R., Cox J. E., Hoffmann D. Analysis of 1,3-butadiene and other selected gas-phase components in cigarette mainstream and sidestream smoke by gas chromatography-mass selective detection. Carcinogenesis 1990; 11: 1863
  • California Air Resource Board (CARB), Proposed identification of 1,3-butadiene as a toxic air contaminant. Part B. Health assessment. Office of Environmental Health Hazard Assessment, California Environmental Protection Agency. 1992
  • Carpenter C. P., Shaffer C. B., Weil C. S., Smyth H. F., Jr. Studies on the inhalation of 1:3-butadiene; with a comparison of its narcotic effects with benzol, toluol, and styrene, and a note on the elimination of styrene by the human. J. Ind. Hyg. Toxicol 1944; 26: 69
  • Checkoway H., Wilcosky T., Wolf P., Tyroler H. An evaluation of the associations of leukemia and rubber industry solvent exposures. Am. J. Ind. Med 1984; 5: 239
  • Checkoway H., Williams T. M. A hematologic survey of workers at a styrene-butadiene synthetic rubber manufacturing plant. Am. Ind. Hyg. Assoc. J 1982; 43: 164
  • Chemical Engineering News, Top 50 chemical production rose modestly last year. Chem. Eng. News April, 1994; 11: 12
  • Chemical Week, CW product focus: butadiene. Chem. Week June, 1994; 15: 56
  • Cheng X., Ruth R. A. A simplified methodology for quantitation of butadiene metabolites: application to the study of 1,3-tmtadiene metabolism by rat liver mi-crosomes. Drug Metab. Dispos 1993; 21: 121
  • Choudhary G. Environmental exposure to 1,3-butadiene: a human health perspective. Environ. Carcinogen. Ecotoxicol. Rev 1994; C12: 23
  • Citti L., Gervasi P. G., Turchi G., Bellucci G., Bianchini R. The reaction of 3,4-epoxy-1-butene with deoxyguanosine and DNA in-vitro: synthesis and characterization of the main adducts. Carcinogenesis 1984; 5: 47
  • Cochrane J. E., Skopek T. R. Mutagenicity of 1,3-butadiene and its epoxide metabolites. II. Mutational spectra of butadiene, 1,2-epoxybutene and diepoxy-butane at thehprt locus in splenic T cells from exposed B6C3F1 mice. Carcinogenesis 1994a; 15: 719
  • Cochrane J. E., Skopek T. R. Mutagenicity of butadiene and its epoxide metabolites. I. Mutagenic potential of 1,2-epoxybutene, 1,2,3,4-diepoxybutane and 3,4-epoxy-1,2-butanediol in cultured human lymphoblasts. Carcinogenesis 1994b; 15: 713
  • Colagiovanni D. B., Stillman W. S., Irons R. D. Chemical suppression of a subpopulation of primitive hematopoietic progenitor cells: 1,3-butadiene produces a hematopoietic defect similar to Steel or White Spotted mutations in mice. Proc. Natl. Acad. Sci. U.S.A 1993; 90: 2803
  • Cole P. Direct testimony before the Occupational Safety and Health Administration October, 1990
  • Cole P., Delzell E., Acquavella J. Exposure to butadiene and lymphatic and hematopoietic cancer. Epidemiology 1993; 4: 86
  • Cote I. L., Bayard S. P. Cancer risk assessment of 1,3-butadiene. Environ. Health Perspect 1990; 86: 149
  • Cowles S. R., Tsai S. P., Snyder P. J., Ross C. E. Mortality, morbidity, and haematologic results from a cohort of long term workers involved in 1,3-butadiene monomer production. Occup. Environ. Med 1994; 51: 323
  • Crouch C. N., Pullinger D. H., Gaunt I. F. Inhalation toxicity studies with 1,3-butadiene. II. 3 month toxicity studies in rats. Am. Ind. Hyg. Assoc. J 1979; 40: 796
  • Csanády G. A., Guengerich F. P., Bond J. A. Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice. Carcinogenesis 1992; 13: 1143
  • Cunningham M. J., Choy W. N., Arce G. T., Rickard L. B., Vlachos D. A., Kinney L. A., Sarrif A. M. In vivo sister chromatid exchange and micro-nucleus induction studies with 1,3-butadiene in B6C3F1 mice and Sprague-Dawley rats. Mutagen-esis 1986; 1: 449
  • Dahl A. R., Sun J. D., Birnbaum L. S., Bond J. A., Griffith W. C., Jr., Mauderly J. L., Muggenburg B. A., Saboruin P. J., Henderson R. F. Toxicokinetics of inhaled 1,3-butadiene in monkeys: comparison to toxicokinetics in rats and mice. Toxicol. Appl. Pharmacol 1991; 110: 9
  • Dahl A. R., Bechtold W. E., Bond J. A., Henderson R. F., Mauderly J. L., Muggenburg B. A., Sun J. D., Birnbaum L. S. Species differences in the metabolism and disposition of inhaled 1,3-butadiene and isoprene. Environ. Health Perspect 1990; 86: 65
  • Daubert T. E., Danner R. P. Data compilation tables of properties of pure compounds. Am. Inst. Chem. Eng 1985; 450
  • Davis C. D., Pirmohamed M., Kitteringham N. R., Allott R. L., Smith D., Park B. K. Kinetic parameters of lymphocyte microsomal epoxide hydrolase in carbamazipine hypersensitive patients: assessment by radiometric HPLC. Biochem. Pharmacol 1995; 50: 1361
  • Del Pup J., Kmiecik J., Smith S., Reitman F. Improvement in human health risk assessment utilizing site- and chemical-specific information: a case study. Science and Judgement in Risk Assessment. National Academy Press, New York 1994; 479
  • Delzell E., Sathiakumar N., Macaluso M., Hovinga M., Larson R., Barbone F., Beall C., Cole P. A. Follow-up Study of Synthetic Rubber Workers October, 1995, Final report prepared under contract to International Institute of Synthetic Rubber Producers
  • Delzell E., Sathiakumar N., Macaluso M., Hovinga M., Larson R., Barbone F., Beall C., Cole P. A. Follow-up study of synthetic rubber workers. Toxicology 1996; 113: 182
  • de Meester C. Genotoxic properties of 1,3-butadiene. Mutat. Res 1988; 195: 273
  • Deutschmann S., Laib R. J. Concentration-dependent depletion of non-protein sulfhydryl (NPSH) content in lung, heart, and liver tissue of rats and mice after acute inhalation exposure to butadiene. Toxicol. Lett 1989; 45: 175
  • Divine B. J. An update on mortality among workers at a butadiene facility: preliminary results. Environ. Health Perspect 1990; 86: 119
  • Divine B. J., Wendt J. K., Hartman C. M. Cancer mortality among workers at a butadiene production facility 1. ARC Sci. Publ 1993; 127: 345
  • Divine B. J., Hartman C. M. Mortality update of butadiene production workers. Toxicology 1996; 113: 169
  • Doerr J. K., Hooser S. B., Smith B. J., Sipes I. G. Ovarian toxicity of 4-vinylcyclohexene and related ole-fins in B6C3F1 mice: role of diepoxides. Chem. Res. Toxicol 1995; 8: 963
  • Downs T. D., Crane M. M., Kim K. W. Mortality among workers at a butadiene facility. Am. J. Ind. Med 1987; 12: 311
  • Downs T., Pier S., Crane M., Yim K., Kim K. Cause-specific mortality in a cohort of 1000 ABS workers. Abstr. Symp. — Butadiene and Styrene: Assessment of Health Hazards. EspooFinland 1992
  • Duescher R. J., Elfarra A. A. Human liver microsomes are efficient catalysts for 1,3-butadiene oxidation: evidence for major roles by cytochrome P450 2A6 and 2E1. Arch. Biochem. Biophys 1994; 311: 342
  • Duescher R. J., Elfarra A. A. Chloroperoxidase-mediated oxidation of 1,3-butadiene to 3-butenal, a crotonaldehyde precursor. Chem. Res. Toxicol 1993; 6: 669
  • Duescher R. J., Elfarra A. A. 1,3-Butadiene oxidation by human myeloperoxidase: role of chloride ion in catalysis of divergent pathways. J. Biol. Chem 1992; 267: 19859
  • Elfarra A. A., Sharer J. E., Duescher R. J. Synthesis and characterization of N-acetyl-L-cysteine S-conju-gates of butadiene monoxide and their detection and quantitation in urine of rats and mice given butadiene monoxide. Chem. Res. Toxicol 1995; 8: 68
  • Elfarra A. A., Duescher R. J., Pasch C. M. Mechanisms of 1,3-butadiene oxidations to butadiene monoxide and crotonaldehyde by mouse liver microsomes and chloroperoxidase. Arch. Biochem. Biophys 1991; 286: 244
  • Elovaara E., Merman-Golkar S., Nakajima T., Gelboin H. V., Riihimaki V., Sorsa M. 1.3-Butadiene exposure of rats: hemoglobin adducts of 1,2-epoxybutene and cytochrome P450-related changes in styrene metabolism. Cytochrome P450, M. C. Lechner. Libbey Eurotext, Paris 1994; 567
  • Environ. Assessment of the Potential Risks to Workers from Exposure to 1,3-Butadiene. Chemical Manufacturers Association, Washington, DC 1986
  • European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC), No. 4. 1,3-Butadiene Criteria Document. Belgium 1993, Avenue E, Van Nieuwenhuyse 4, B. 6, B-1160 Brussels
  • Evelo C. T. A., Oostendorp J. G. M., ten Berge W. F., Borm J. A. Physiologically based toxicokinetic modeling of 1,3-butadiene lung metabolism in mice becomes more important at low doses. Environ. Health Perspect 1993; 101: 496
  • Fajen J. M., Roberts D. R., Ungers L. J., Krishnan E. R. Occupational exposure of workers to 1,3-butadiene. Environ. Health Perspect 1990; 86: 11
  • Fajen J. M., Lunsford R. A., Roberts D. R. Industrial exposure to 1,3-butadiene in monomer, polymer, and end user industries. Butadiene and Styrene: Assessment of Health Hazards, M. Sorsa, K. Peltonen, H. Vainio, K. Hemminki. 1ARC Scientific Publication, Lyon 1993; 127: 3
  • Filser J. G., Bolt H. M. Inhalation pharmacokinetics based on gas uptake studies. VI. Comparative evaluation of ethylene oxide and butadiene monoxide as exhaled reactive metabolites of ethylene and 1,3-butadiene in rats. Arch. Toxicol 1984; 55: 219
  • Freeman J. E., Stirling D. A., Russell A. L., Wolf C. R. cDNA sequence, deduced amino acid sequence, predicted gene structure and chemical regulation of CYP2E1. Biochem. J 1992; 281: 689
  • Gardner M. J., Osmond C., Pannett B., Acheson E. D. Reply to Letter to the Editor. Lancet 1986; 1: 437
  • Gargas M. L., Medinsky M. A., Andersen M. E. Pharmacokinetic modeling for describing the uptake, systemic distribution, and disposition of inhaled chemicals. Crit. Rev. Toxicol 1995; 25: 237
  • Gay P., Contamine D. Study of theref(2)P lous of Drosophila melanogaster. Mol. Gen. Genet 1993; 239: 361
  • Goodrow T., Reynolds S., Maronpot R., Anderson M. Activation of K-ras by codon 13 mutations in C57BL/ 6 C3H F1 mouse tumors induced by exposure to 1,3-butadiene. Cancer Res 1990; 50: 4818
  • Goodrow T. L., Nichols W. W., Storer R. D., Anderson M. W., Maronpot R. R. Activation of H-ras is prevelant in 1,3-butadiene-induced and spontaneously occurring murine Harderian gland tumors. Cancer Res 1994; 55: 2665
  • Grossman E. A., Martonik J. OSHA's approach to risk assessment for setting a revised occupational exposure standard for 1,3-butadiene. Environ. Health Perspect 1990; 86: 155
  • Hackett P. L., Brown M. G., Clark M. L., Evanoff J. J., Rowe S. E., McClananhan B. J., Buschbom R. L., Decker J. R., Rommereim R. L., Westerberg R. B. Sperm-head morphology study in B6C3F1 mice following inhalation exposure to 1,3-butadiene. National Institute of Environmental Health Sciences, National Toxicology Program, Pacific Northwest Laboratory, Battelle Memorial Institute, Richland, WA 1988a, unpublished, Final Technical Report No. NIH-Y01-ES-70153
  • Hackett P. L., Mast T. J., Brown M. G., Clark M. L., Evanoff J. J., Rowe S. E., McClananhan B. J., Buschbom R. L., Decker J. R., Rommereim R. L., Westerberg R. B. Dominant lethal study in CD-1 mice following inhalation exposure to 1,3-butadiene, Prepared for the National Institute of Environmental Health Sciences, National Toxicology Program. Pacific Northwest Laboratory, Battelle Memorial Institute, Richland, WA 1988b, Final Technical Report No. NIH-Y01-ES-70153, unpublished
  • Hackett P. L., Sikov M. R., Mast T. J., Brown M. G., Buschbom R. L., Clark M. L., Decker J. R., Evanoff J. J., Rommereim R. L., Rowe S. E., Westerberg R. B. Inhalation developmental toxicology studies of 1,3-butadiene in the rat. National Institute of Environmental Health Sciences, National Toxicology Program, Pacific Northwest Laboratory, Battelle Memorial Institute, Richland, WA 1987a, unpublished, Final Report No. NIH-401-ES-40131
  • Hackett P. K., Sikov M. R., Mast T. J., Brown M. G., Buschbom R. L., Clark M. L., Decker J. R., Evanoff J. J., Rommereim R. L., Rowe S. E., Westerberg R. B. Inhalation developmental toxicology studies: teratology study of 1,3-butadiene in mice. National Institute of Environmental Health Sciences, National Toxicology Program, Pacific Northwest Laboratory, Battelle Memorial Institute, Richland, WA 1987b, unpublished, Final Report No. NIH-401-ES-40131
  • Hallenbeck W. H. Cancer risk assessment for the inhalation of 1,3-butadiene using physiologically based pharmacokinetic modeling (PBPK). Bull. Toxicol 1992; 49: 66
  • Hansch C., Leo A. J. Medchem project. Issue No. 26. Pomona College, Claremont, CA 1985
  • Hassett C., Aicher L., Sidhu J. S., Omiecinski C. J. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum. Mol. Genet 1994; 3: 421
  • Hattis D., Wasson J. A pharmacokinetic/mechanism-based analysis of the carcinogenic risk of butadiene. Center of Technology Policy and Industrial Development, Massachusetts Institute of Technology, Cambridge, MA 1987, Report CTPID 87–3
  • Hayes R. B., Xi L., Bechtold W. E., Rothman N., Yao M., Henderson R., Zhang L., Smith M. T., Zhang D., Wiemels J., Dosemeci M., Yin S., O'Neill J. P. hprt Mutation frequency among workers exposed to 1,3-butadiene in China. Toxicology 1996, in press
  • Health Effects Institute (HEI), Research priorities for mobile air toxics: research priorities to reduce uncertainities for 1,3-butadiene. Health Effects Inst. Commun 1993; 2: 44
  • Himmelstein M. W., Turner M. J., Asgharian B., Bond J. A. Comparison of blood concentrations of 1,3-butadiene and butadiene epoxides in mice and rats exposed to 1,3-butadiene by inhalation. Carcinogen-esis 1994; 15: 1479
  • Himmelstein M. W., Asgharian B., Bond J. A. High concentrations of butadiene epoxides in livers and lungs of mice compared to rats exposed to 1,3-butadiene. Toxicol. Appl. Toxicol 1995; 132: 281
  • Hine J., Mookerjee P. K. The intrinsic hydrophilic character of organic compounds. Correlations in terms of structural contributions. J. Org. Chem 1975; 40: 292
  • Hirvonen A., Husgafvel-Pursiainen K., Anttila S., Vainio H. The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis 1993; 14: 1479
  • Huff J. E., Melnick R. L., Solleveld H. A., Haseman J. K., Powers M., Miller R. A. Multiple organ carcinogenicity of 1,3-butadiene in B6C3F1 mice after 60 weeks of inhalation exposure. Science 1985; 227: 548
  • International Agency for Research on Cancer (IARC), IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans. Butadiene. World Health Organization, LyonFrance 1986; Vol. 39: 155, 1–3
  • International Agency for Research on Cancer (IARC),IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Occupational Exposures to Mists and Vapors from Strong Inorganic Acids; and Other Industrial Chemicals. World Health Organization, LyonFrance 1992; Vol. 54
  • ICF/Clement, Characterization of risks associated with occupational exposure to 1,3-butadiene. U.S. Department of Labor, Washington, DC 1986, final report, OSHA
  • International Institute of Synthetic Rubber Producers (IISRP), The Toxicity and Carcinogenicity of Butadiene Gas Administered to Rats by Inhalation for Approximately 24 Months. International Institute of Synthetic Rubber Products, Houston, TX 1981a, Report No. 2653–522/2
  • International Institute of Synthetic Rubber Producers (IISRP), 1,3-Butadiene: Inhalation Teratogenicity Study in the Rat. International Institute of Synthetic Rubber Products, Houston, TX 1981b, Report No. 2788–522/3
  • Irons R. D., Le A. T., Som D. B., Stillman W. S. 2′,3′-Dideoxycytidine-induced thymic lymphoma correlates with species-specific suppression of a subpopu-lation of primitive hematopoietic progenitor cells in mouse but not rat or human bone marrow. J. Clin. Invest 1995; 95: 2777
  • Irons R. D., Colagiovanni D. B., Stillman W. S. Murine thymic lymphoma is associated with a species-specific hematopoietic progenitor cell population. Toxicology 1996, in press
  • Irons R. D., Smith C. N., Stillman W. S., Shah R. S., Steinhagen W. H., Leiderman L. J. Macro-cytic-megaloblastic anemia in male B6C3F1 mice following chronic exposure to 1,3-butadiene. Toxicol. Appl. Pharmacol 1986a; 83: 95
  • Irons R. D., Smith C. N., Stillman W. S., Shah R. S., Steinhagen W. H., Leiderman L. J. Macro-cytic-megaloblastic anemia in male NIH Swiss mice following repeated exposure to 1,3-butadiene. Toxicol. Appl. Pharmacol 1986b; 85: 450
  • Irons R. D., Stillman W. S., Cloyd M. W. Selective activation of endogenous ecotropic retrovirus in hematopoietic tissues of B6C3F1 mice during the preleu-kemic phase of 1,3-butadiene exposure. Virology 1987; 161: 457
  • Irons R. D., Cathro H. P., Stillman W. S., Steinhagen W. H., Shah R. S. Susceptibility to 1,3-butadi-ene-induced leukemogenesis correlated with endogenous ecotropic retroviral background in the mouse. Toxicol. Appl. Pharmacol 1989; 191: 170
  • Irvine L. F.H. 1,3-Butadiene: inhalation teratogenicity study in the rat. Hazleton Laboratories Europe Ltd., HarrogateEngland 1981, Final Report, OTS Submission, Microfiche No. 050 545
  • Jauhar P. P., Henika P. R., MacGregor J. T., Wehr C. M., Shelby M. D., Murphy S. A., Margolin B. H. 1,3-Butadiene: induction of micronucleated eryth-rocytes in the peripheral blood of B6C3F1 mice exposed by inhalation for 13 weeks. Mutat. Res 1988; 209: 171
  • Johanson G., Filser J. G. A physiologically based pharmacokinetic model for butadiene and its metabolite butadiene monoxide in rat and mouse and its significance for risk extrapolation. Arch. Toxicol 1993; 67: 151
  • Kelsey K. T., Christiani D. C., Wiencke J. K. Bimodal distribution of sensitivity to SCE induction by diepoxybutane in human lymphocytes. II. Relationship to baseline SCE frequency. Mutat. Res 1991; 248: 27
  • Kirshenbaum I. Butadiene. Encyclopedia of Chemical Technology3rd ed., A. Stannden, Kirk-Othmer. John Wiley & Sons, New York 1978; Vol. 4: 313
  • Kohn M. C., Melnick R. L. Species differences in the production and clearance of 1.3-butadiene metabolites: a mechanistic model indicates predominantly physiological, not biochemical, control. Carcinogenesis 1993; 14: 619
  • Kreiling R., Laib R. J., Bolt H. M. Alkylation of nuclear proteins and DNA after exposure of rats and mice to [l,4-14C]l,3-butadiene. Toxicol. Lett 1986a; 30: 131
  • Kreiling R., Laib R. J., Filser J. G., Bolt H. M. Species differences in butadiene metabolism between mice and rats evaluated by inhalation pharmacokientics. Arch. Toxicol 1986b; 58: 235
  • Kreiling R., Laib R. J., Filser J. G., Bolt H. M. Inhalation pharmacokinetics of 1,2-epoxy-butene-3 reveal species differences between rats and mice sensitive to butadiene-induced carcinogenesis. Arch. Toxicol 1987; 61: 7
  • Kreiling R., Laib R. J., Bolt H. M. Depletion of hepatic non-protein sulfhydryl content during exposure of rats and mice to butadiene. Toxicol. Lett 1988; 41: 209
  • Kreuzer P. E., Kessler W., Welter H. F., Baur C., Filser J. G. Enzyme specific kinetics of 1.2-epoxybutene-3 in microsomes and cytosol from livers of mouse, rat, and man. Arch. Toxicol 1991; 65: 59
  • Krishnan K., Andersen M. E. Physiolgically based pharmacokinetic modeling in toxicology. Principles and Methods of Toxicology, A. W. Hayes. Raven Press, New York 1994; 149
  • Krosehwitz J. I., Howe-Grant M. Butadiene. Encyclopedia of Chemical Technology4th ed., A. Stannden, Kirk-Othmer. John Wiley & Sons, New York 1992; Vol. 4: 663
  • Laib R. J., Filser J. G., Kreiling R., Vangala R. R., Bolt H. M. Inhalation pharmacokinetics of 1,3-butadi-ene and 1,2-epoxybutene-3 in rats and mice. Environ. Health Perspect 1990; 86: 57
  • Landrigan P. J. Critical assessment of epidemiologic studies on the human carcinogenicity of 1.3-butadiene. Environ. Health Perspect 1990; 86: 143
  • Landrigan P. J. Critical assessment of epidemiologic studies on the human carcinogenicity of 1,3-butadiene and styrene. Butadiene and Styrene: Assessment of Health Hazards, M. Sorsa, K. Peltonen, H. Vainio, K. Hemminki. IARC Scientific Publication, Lyon 1993; 127: 375
  • Lawley P. D., Brooks P. Further studies on the alkylation of nucleic acids and their constituent nucleotides. Biochem. J 1963; 89: 127
  • Lawley P. D., Brooks P. Interstrand cross-linking of DNA. by difunctional alkylating agents. J. Mol. Biol 1967; 25: 143
  • Leiderman L. J., Stillman W. S., Shah R. S., Steinhagen W. H., Irons R. D. Altered hematopoietic stem cell development in male B6C3F1 mice following exposure to 1,3-butadiene. Exp. Mol. Pathol 1986; 44: 50
  • Leuratti C., Marafante E., Jones N. J., Waters R. Detection by HPLC-32P-postlabelling of DNA adducts formed after exposure to epoxybutane and diepoxy-butane. Postlabelling Methods for Detection of DNA Adducts, D. H. Phillips, M. Castegnaro, H. Bartsch. IARC Scientific Publications, Lyon 1993; 124: 277
  • Li C. Y., Yandell D. W., Little J. B. Molecular mechanisms of spontaneous and induced loss of het-erozygosity in human cells in-vitro. Somatic Cell and Mol. Genet 1992; 18: 77
  • Lichtenberg G., Nowak C., Gleier K., Meckert C., Richter-Reichhelm R.-B. Anchorage independent colony growth of fetal hamster lung epithelial cells after treatment with diepoxybutane. Toxicol. Lett 1995; 75: 193
  • Lide D. R. CRC Handbook of Chemistry and Physics75th ed., H. P. R. Frederikse. CRC Press, Boca Raton, FL 1994; 1625
  • Löfroth G., Burton R. M., Forehand L., Hammond S. K., Sella R. L., Zweidinger R. B., Lewtas J. Characterization of environmental tobacco smoke. Environ. Sci. Technol 1989; 23: 610
  • Lyman W. J., Reehl W. F., Rosenblatt D. H. Handbook of Chemical Property Estimation Methods, chap. 4, 5, and 15,. McGraw-Hill, New York 1982
  • Malvoisin E., Lhoest G., Poncelet F., Roberfroid M., Mercier M. Identification and quantitation of l,2-epoxybutene-3 as the primary metabolite of 1,3-butadiene. J. Chromatogr 1979a; 178: 419
  • Malvoisin E., Evrard E., Roberfroid M., Mercier M. Determination of Kováts retention indices with a capillary column and electron capture detection: application to the assay of the enzymatic conversion of 3,4-epoxy-1-butene into diepoxybutane. J. Chromatogr 1979b; 179: 81
  • Malvoisin E., Roberfroid M. Hepatic microsomal metabolism of 1,3-butadiene. Xenobiotica 1982; 12: 137
  • Maniglier-Poulet C., Cheng X., Ruth J. A., Ross D. Metabolism of 1,3-butadiene to butadiene monoxide in mouse and human bone marrow cells. Chem. Biol. Int 1995; 97: 119
  • Matanoski G. M., Santos-Burgoa C. Butadiene and lymphatic and hematopoietic cancer (Letter to the Editor). Epidemiology 1994; 5: 261
  • Matanoski G. M., Santos-Burgoa C., Zeger S., Schwartz L. Nested case control study of lymphopoietic cancers in workers of the styrene-butadiene polymer manufacturing industry April, 1989, Final report prepared under contract to International Institute of Synthetic Rubber Producers
  • Matanoski G. M., Santos-Burgoa C., Schwartz L. Mortality of a cohort of workers in the styrene-butadiene polymer manufacturing industry 1943–1982 April, 1988, Final report prepared under contract to International Institute of Synthetic Rubber Producers
  • Matanoski G. M., Schwartz L. Mortality of workers in styrene-butadiene polymer production. J. Occup. Med 1987; 29: 675
  • Matanoski G. M., Santos-Burgoa C., Schwartz L. Mortality of a cohort of workers in the styrene-butadiene polymer manufacturing industry. Environ. Health Perspect 1990; 86: 107
  • McAuliffe C. Solubility in water of paraffin, cycloparaffin, olefin, acetylene, cycloolefin and aromatic hydrocarbons. J. Phys. Chem 1966; 70: 1267
  • McGraw J. Supplemental Written Testimony to the Occupational Safety and Health Administration — Part B. Time Weighted Average Exposure Data. Part C. “Short-term” Exposure Data November, 1990
  • McMichael A. J., Spirtas R., Gamble J. F., Tousey P. M. Mortality among rubber workers: relationship to specific jobs. J. Occup. Med 1976; 18: 178
  • MCA, Chemical safety data sheet SD-55, Properties and essential information for safe handling and use of butadiene. Manufacturing Chemists Association, Washington, DC 1974
  • Medinskv M. A., Leavens T. L., Csanády G. A., Gargas M. L., Bond J. A. In vivo metabolism of butadiene by mice and rats: a comparison of physiological model predictions and experimental data. Carcinogen-esis 1994; 15: 1329
  • Medinsky M. A., Klaassen C. D. Toxicokinetics. Casarette and Doull's Toxicology, The Basic Science of Poisons5th ed., C. D. Klaassen. McGraw-Hill, New York, 187
  • Meinhardt T. J., Lenien R. A., Crandall M. S., Young R. J. Environmental epidemiologic investigations of the styrene-butadiene rubber industry. Scand. J. Work Environ. Health 1982; 8: 250
  • Melnick R. L., Huff J. E., Haseman J. K., McConnell E. E. Chronic toxicity results and ongoing studies of 1,3-butadiene by the National Toxicology Program. Ann. N.Y. Acad. Sci 1988; 534: 648
  • Melnick R., Huff J., Miller R. Toxicology and carcinogenicity of 1,3-butadiene. Assessment of Inhalation Hazards: Integration and Extrapolation Using Diverse Data, U. Mohn. Springer-Verlag, New York 1989; 177
  • Melnick R. L., Huff J. E., Bird M. G., Acquavella J. A. Symposium overview: Toxicology, carcinogen-esis, and human health aspects of 1,3-butadiene. Environ. Health Perspect 1990a; 86: 3
  • Melnick R. L., Huff J., Chou B. J., Miller R. A. Carcinogenicity of 1,3-butadiene in C57B1/6 x C3HF1 mice at low exposure concentrations. Cancer Res 1990b; 50: 6592
  • The Merck Index. An Encyclopedia of Chemicals, Drugs, and Biologicals11th ed., S. Budavari. Merck and Co., Rahway, NJ 1989; 230
  • Miettinen O. S. Theoretical Epidemiology. John Wiley & Sons, New York 1985
  • Miller L. M. Investigation of selected potential environmental contaminants: butadiene and its oligomers. Franklin Research Center, Philadelphia, PA 1978, EPA 560/ 2–78–008
  • Morrissey R. E., Schwetz B. A., Hackett P. L., Sikov M. R., Hardin B. D., McClanahan B. J., Decker J. R., Mast T. J. Overview of reproductive and developmental toxicity studies of 1,3-butadiene in rodents. Environ. Health Perspect 1990; 86: 79
  • National Research Council (NRC). Science and Judgement in Risk Assessment. National Academy Press, Washington, DC 1994
  • National Toxicology Program (NTP). Research Triangle Park, NC 1984, Toxicology and car-cinogenesis studies of 1,3-butadiene (CAS No. 106–99–0) in B6C3F1 mice (inhalation studies), NTP TR No. 288, 1–111
  • National Toxicology Program (NTP). Research Triangle Park, NC 1993, NTP Technical Report on the Toxicology and Carcinogenesis studies of 1,3-Butadiene, NTP TR 434, No. 93–3165, 1–391
  • Nauhaus S. K., Fennell T. R., Asgharian B., Bond J. A., Sumner S. C-J. Characterization of urinary metabolites from Sprague-Dawley rats and B6C3F1 mice exposed to [1,2,3,4-13C]butadiene. Chem. Res. Toxicol 1996; 9: 764
  • Neagu I., Koivisto P., Neagu C., Kostiainen R., Stenby K., Peltonen K. Butadiene monoxide and deoxyguanosine alkylation products at the N7-position. Carcinogenesis 1995; 16: 1809
  • Neligan R. E. Hydrocarbons in the Los Angeles atmosphere. Arch. Environ. Health 1962; 5: 581
  • NIOSH, A quantitative assessment of the risk of cancer associated with exposure to 1,3-butadiene, based on a low dose inhalation study in B6C3F1 mice. National Institute for Occupational Safety and Health. 1992
  • Nicklas J. A., O'Neill J. P., Albertini R. J. Use of T-cell receptor gene probes to quantify thein vivo hprt mutations in human T-lymophocytes. Mutat. Res 1986; 173: 65
  • Norppa H., Hirvonen A., Järventaus H., Uusküla M., Tasa G., Ojajrvi A., Sorsa M. Role of GSTT1 and GSTM1 genotypes in determining individual sensitivity to sister chromatid exchange by diepoxybutane in cultured human lymphocytes. Carcinogenesis 1995; 16: 1261
  • Occupational Safety and Health Administration, Occupational Exposure to 1,3 butadiene: proposed rule. Fed. Regist August, 1990; 55: 32747, 10
  • Osterman-Golkar S. M., Bond J. A., Ward J. B., Legator M. S. Use of haemoglobin adducts for biomonitoring exposure to 1,3-butadiene. Butadiene and Styrene: Assessment of Health Hazards, M. Sorsa, K. Peltonen, H. Vainio, K. Hemminki. IARC Scientific Publication, Lyon 1993; 127: 124
  • Osterman-Golkar S. M., Kautiainen A., Bergmark E., Hakansson K., Måki-Paakkanen J. Hemoglobin adducts and urinary mercapturic acids in rats as biological indictors of butadiene exposure. Chem.-Biol. Interact 1991; 80: 291
  • Ott M. G. Assessment of 1,3-butadiene epidemiology studies. Environ. Health Perspect 1990; 86: 135
  • Owen P. E., Glaister J. R. Inhalation toxicity and carcinogenicity of 1,3-butadiene in Sprague-Dawley rats. Environ. Health Perspect 1990; 86: 19
  • Owen Glaister P. E. J. R., Gaunt I. F., Pullinger D. H. Inhalation toxicity studies with 1,3-butadiene. III. Two year toxicity/carcinogencity study in rats. Am. Ind. Hyg. Assoc. J 1987; 48: 407
  • Peltonen K., Koivisto P., Neagu I., Kostianinen R., Kilpeläinen I., Sorsa M. Estimating internal dose of 1,3-butadiene: preliminary data on use of modified purine bases as markers of exposure. Butadiene and Styrene: Assessment of Health Hazards, M. Sorsa, K. Peltonen, H. Vainio, K. Hemminki. IARC Scientific Publications, LyonFrance 1993; 127: 119
  • Pelz N., Dempster A. M., Shore P. R. Analysis of low molecular weight hydrocarbons including 1,3-butadiene in engine exhaust gases using an aluminum oxide porous-layer open-tubular fused-silica column. J. Chromatogr. Sci 1990; 28: 238
  • Pemble S., Schroeder K. R., Spencer S. R., Meyer D. J., Hallier E., Bolt H. M., Ketterer B., Taylor J. B. Human glutathione S-transferase J (GSTT1): cDNA cloning and characterization of a genetic polymorphism. Biochem. J 1994; 300: 271
  • Ramsey J. C., Andersen M. E. A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicol. Appl. Pharmacol 1984; 73: 159
  • Reardon J. T., Liljestrand-Golden C. A., Dusenberry R. L., Smith P. D. Molecular analysis of diepoxybutane-induced deletions at the rosy locus of Drosophila melanogaster. Genetics 1987; 115: 323
  • Recio L., Meyer K. Increased frequency of mutations at A:T base pairs in the bone marrow of B6C3F1lacl transgenic mice exposed to 1,3-butadiene. Environ. Mol. Mutagen, in press
  • Recio L., Cochrane J., Simpson D., Skopek T. R., O'Neill J. P., Nicklas J. A., Albertini R. J. DNA sequence analysis ofin vivo hprt mutation in human T-lymphocytes. Mutagenesis 1990; 5: 505
  • Recio L., Osterman-Golkar S., Csanády G. A., Turner M. J., Myhr B., Moss O., Bond J. A. Determination of mutagenicity in tissues of transgenic mice following exposure to 1,3-butadiene and N-ethyl-N-nitrosourea. Toxicol. Appl. Pharmacol 1992; 117: 58
  • Rodger R. S., Fletcher K., Fail B. J., Rahman H., Sviland L., Hamilton P. J. Factors influences haematological measurements in healthy adults. J. Chron. Dis 1977; 40: 943
  • Rothman K. J. Modern Epidemiology. Little, Brown, Boston 1986
  • Sabourin P. J., Burka L. T., Bechtold W. E., Dahl A. R., Hoover M. D., Chang I.-Y., Henderson R. F. Species differences in urinary butadiene metabolites; identification of l,2-dihydroxy-4-(N-acetyI-cysteinyl)butane, a novel metabolite of butadiene. Car-cinogenesis 1992; 13: 1633
  • Santos-Burgoa C., Matanoski G. M., Zeger S., Schwartz L. Lympho-hematopoietic cancer in sty-rene-butadiene polymerization workers. Am. J. Epidemiol 1992; 136: 843
  • Sasiadek M., Jarentaus H., Sorsa M. Sister-chro-matid exchanges induced by 1,3-butadiene and its ep-oxides in CHO cells. Mutat. Res 1991a; 263: 47
  • Sasiadek M., Norppa H., Sorsa M. 1,3-Butadiene and its epoxides induce sister-chromatid exchanges in human lymphocytes in-vitro. Mutat. Res 1991b; 261: 117
  • Sax N. I., Lewis R. J. Hawley's Condensed Chemical Dictionary11th ed. Van Nostrand Reinhold, New York 1987; 177
  • Schmidt U., Loeser E. Species differences in the formation of butadiene monoxide from 1,3-butadiene. Arch. Toxicol 1985; 57: 222
  • Seaton M. J., Follansbee M. H., Bond J. A. Oxidation of l,2-epoxy-3-butene to l,2:3,4-diepoxybutane by cDNA-expressed human cytochrome P450 2E1 and 3A4 and human, mouse and rat liver microsomes. Carcino-genesis 1995; 16: 2287
  • Selzer R. R., Elfarra A. A. Synthesis and biochemical characterization of N1-, N2-, and N7-guanosine adducts of butadiene monoxide. Chem. Res. Toxicol 1996; 9: 126
  • Sharer J. E., Duescher R. J., Elfarra A. A. Formation, stability, and rearrangements of the glutathione conjugates of butadiene monoxide: evidence for the formation of stable sulfurane intermediates. Chem. Res. Toxicol 1991; 4: 430
  • Sharer J. E., Duescher R. J., Elfarra A. A. Species and tissue differences in the microsomal oxidation of 1,3-butadiene and the glutathione conjugation of butadiene monoxide in mice and rats: possible role in 1,3-butadiene-induced toxicity. Drug Metab. Dispos 1992; 20: 658
  • Sharer J. E., Elfarra A. A. S-(2-hydroxy-3-buten-l-yl)glutathione and S-(l-hydroxy-3-buten-2-yl)gluta-thione arein vivo metabolites of 1,3-butadiene monoxide: detection and quantitation in bile. Chem. Res. Toxicol 1992; 5: 787
  • Shugaev B. B. Concentrations of hydrocarbons in tissues as a measure of toxicity. Arch. Environ. Health 1969; 18: 878
  • Singer B., Grunberger D. Molecular Biology of Mu-tagens & Carcinogens. Plenum Press, New York 1983
  • Sisk S. C., Pluta L. J., Bond J. A., Recio L. Molecular analysis oflacl mutants from bone marrow of B6C3F1 transgenic mice following inhalation exposure to 1,3-butadiene. Carcinogenesis 1994; 15: 471
  • Sorsa M., Autio K., Demopoulos N. A., Järventaus H., Rössner P., Srám R. J., Stephanou G., Vlachodimitropoulos D. Human cytogenetic bio-monitoring of occupational exposure to 1,3-butadiene. Mutat. Res 1994; 309: 321
  • St. Pierre M. V., Pang K. S. Kinetics of sequential metabolism. I. Formation and metabolism of oxazepam from nordiazepam and temazepam in the perfused murine liver. J. Pharmacol. Exp. Ther 1993; 265: 1429
  • Stewart P. A., Schairer C., Blair A. Comparison of jobs, exposures, and mortality risks for short-term and long-term workers. J. Occup. Med 1990; 32: 703
  • Tates A. D., van Dam F. J., de Zwart F. A., van Teylingen C. M. M., Natarajan A. T. Development of a cloning assay with high cloning efficiency to detect induction of 6-thioguanine-resistant lymphocytes in spleen of adult mice followingin vivo inhalation exposure to 1,3-butadiene. Mutat. Res 1994; 309: 299
  • Thier R., Müller M., Taylor J. B., Pemble S. E., Ketterer B., Guengerich F. P. Enhancement of bacterial mutagenicity of bifunctional alkylating agents by expression of mammalian glutathione S-transferase. Chem. Res. Toxicol 1995; 8: 465
  • Thornton-Manning J. R., Dahl A. R., Bechtold W. E., Griffith W. C., Jr., Henderson R. F. Disposition of butadiene monoepoxide and butadiene diepoxide in various tissues of rats and mice following a low-level inhalation exposure to 1,3-butadiene. Carcinogenesis 1995a; 16: 1723
  • Thornton-Manning J. R., Dahl A. R., Bechtold W. E., Griffith W. C., Jr., Pei L., Henderson R. F. Gender differences in the metabolism of 1,3-butadiene in Sprague-Dawley rats following a low-level inhalation exposure. Carcinogenesis 1995b; 16: 2875
  • Thurmond L. M., Lauer L. D., House R. V., Stillman W. S., Irons R. D., Steinhagen W. H., Dean J. H. Effect of short-term inhalation exposure to 1,3-butadiene on murine immune functions. Toxicol. Appl. Pharmacol 1986; 86: 170
  • Tice R. R., Ivett J. L. Cytogenetic analysis of bone marrow. Toxicology of the Blood and Bone Marrow, R. D. Irons. Raven Press, New York 1985
  • Tice R. R., Boucher R., Luke C. A., Shelby M. D. Comparative cytogenetic analysis of bone marrow damage induced in male B6C3F1 mice by multiple exposures to gaseous 1,3-butadiene. Environ. Mutagen 1987; 9: 235
  • Turnbull D., Rodricks J. V., Brett S. M. Assessment of the potential risk to workers from exposure to 1,3-butadiene. Environ. Health Perspect 1990; 86: 159
  • U.S. Environmental Protection Agency (EPA), Cancer Risk from Outdoor Exposure to Air Toxics. Washington, DC 1990; Vol. 2, Appendices (EPA-450/1-90–004b)
  • U.S. Environmental Protection Agency (EPA), Non-methane Organic Compound Monitoring Program. Washington, DC 1989; Vol. 2, (Final Report 1988), Urban Air Toxics Monitoring Program (PB90–146697)
  • U.S. Environmental Protection Agency (EPA), Mutagenicity and Carcinogenicity Assessment of 1,3-Butadi-ene. Office of Health and Environmental Assessment, Office of Research and Development, Washington, DC 1985a
  • U.S. Environmental Protection Agency (EPA), Assessment of 1,3-butadiene as a potentially toxic air pollutant. Fed. Regist 1985b; 50(197)41466
  • Uusküla M., Järventaus H., Hirvonen A., Sorsa M., Norppa H. Influence of GSTM1 genotype on sister chromatid exchange induction by styrene-7,8-oxide and 1,2-epoxy-3-butene in cultured human lymphocytes. Carcinogenesis 1995; 16: 947
  • van Duuren B. L., Nelson N., Orris L., Palmes E. D., Schmitt F. L. Carcinogenicity of epoxides, lac-tones, and peroxy compounds. J. Natl. Cancer Inst 1963; 31: 41
  • van Duuren B. L., Langoeth L., Orris L., Teebor G., Nelson N., Kuschner M. Carcinogenicity of epoxides, lactones, and peroxy compounds. IV. Tumor response in epithelial and connective tissue in mice and rats. J. Natl. Cancer Inst 1966; 37: 825
  • Vangala R. R., Laib R. J., Bolt H. M. Evaluation of DNA damage by alakaline elution technique after inhalation exposure of rats and mice to 1,3-butadiene. Arch. Toxicol 1993; 67: 34
  • van Sittert J., van Vliet E. W.N. Monitoring occupational exposure to some industrial chemicals by determining hemoglobin adducts. Clin. Chem 1994; 40: 1472
  • Verschueren K. Handbook of Environmental Data on Organic Chemicals. Van Nostrand Reinhold, New York 1983; 296
  • Ward E. M., Fajen J. M., Ruder A., Rinsky R. A., Halperin W. E., Fessler-Flesch C. A. Mortality study of workers in 1,3-butadiene production units identified from a chemical workers cohort. Environ. Health Perspect 1995; 103: 598
  • Ward J. B., Jr., Ammenheuser M. M., Whorton E. B., Jr., Bechtold W. E., Kelsey K. T., Legator M. S. Biological monitoring for mutagenic effects of occupational exposure to butadiene. Toxicology 1996; 113: 157
  • Ward J. B., Jr., Ammenheuser M. M., Bechtold W. E., Whorton E. B., Jr., Legator M. S. hprt Mutant lymphocyte frequencies in workers at a 1,3-butadiene production plant. Environ. Health Perspect 1994; 102: 79
  • Weast R. C., Astle M. J., Beyer W. H. CRC Handbook of Chemistry and Physics69th ed. CRC Press, Boca Raton, FL 1988; C-161
  • Wiencke J. K., Pemble S., Ketterer B., Kelsey K. Gene deletion of glutathione S-transferase: correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol. Biomark. Prevent 1995; 4: 253
  • Wiencke J. K., Christiani D. C., Kelsey K. T. Bimodal distribution of sensitivity to SCE induction by diepoxybutane in human lymphocytes. I. Correlation with chromosomal aberrations. Mutat. Res 1991a; 248: 17
  • Wiencke J. K., Wrensch M. R., Miike R., Petrakis N. L. Individual susceptibility to induced chromosome damage and its implications for detecting genotoxic exposures in human populations. Cancer Res 1991b; 51: 5266
  • Wilson R. H. Health hazards encountered in the manufacture of synthetic rubber. JAMA 1944; 124: 701
  • Windholz M., Budavari S., Blumetti R. F., Otterbein E. S. The Merck Index. Merck and Co., Rahway, NJ 1983; 209
  • Wiseman R. W., Cochran C., Dietrich W., Lander E. S., Soderkvist P. Allelotyping of butadiene-induced lung and mammary adenocarcinomas of B6C3F1 mice: frequent losses of heterozygosity in regions homologous to human tumor-suppressor genes. Proc. Natl. Acad. Sci. U.S.A 1994; 91: 3759
  • Wistuba D., Nowotny H.-P., Trágerf O., Schurig V. Cytochrome P-450-catalyzed asymmetric epoxi-dation of simple prochiral and chiral aliphatic alk-enes: species dependence and effect of enzyme induction on enantioselective oxirane formation. Chirality 1989; 1: 127
  • Xu X., Pang K. S. Hepatic modeling of metabolite kinetics in sequential and parallel pathways: sali-cylamide and gentisamide metabolism in perfused rat liver. J. Pharmacokinetics Biopharmacol 1989; 17: 645
  • Yamazaki H., Guo Z., Guengerich F. P. Selectivity of cytochrome P4502E1 in chlorzoxazone. Drug Metab. Dispos 1995; 23: 438

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.